Manifold implications of forgotten hyperglycemia in clinical opiate dependence

References

• Adler, M.W., Geller, E.B., Chen, X., Rogers, T.J. (2005). Viewing chemokines as a third major system of communication in the brain. AAPS J 7:E865–E870.
   Google Scholar
• Armario, A. (2010). Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci 31:318–325.
   PubMed Web of Science ®Google Scholar
• Arnsten, J.H., Freeman, R., Howard, A.A., Floris-Moore, M., Lo, Y., Klein, R.S. (2007). Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21:617–623.
   PubMed Web of Science ®Google Scholar
• Beckman, T.R., Shi, Q., Levine, A.S., Billington, C.J. (2009). Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia. Physiol Behav 96:568–573.
   PubMed Web of Science ®Google Scholar
• Behmard, S., Sadeghi, A., Mohareri, M.R., Kadivar, R. (1981). Positive association of opium addiction and cancer of the bladder. Results of urine cytology in 3,500 opium addicts. Acta Cytol 25:142–146.
   PubMed Web of Science ®Google Scholar
• Bernard, M.C. (1877). Learning about diabetes and animal glycogenesis (vol. 1). Paris: Baillière.
   Google Scholar
• Ceriello, A., Giugliano, D., Passariello, N., Quatraro, A., Dello Russo, P., Torella, R., et al. (1987). Impaired glucose metabolism in heroin and methadone users. Horm Metab Res 19:430–433.
   PubMed Web of Science ®Google Scholar
• Ceriello, A., Quatraro, A., Giugliano, D. (1988). Opiate addict as diabetic patient? Diab Care 11:443.
   Web of Science ®Google Scholar
• Cheng, F., McLaughlin, P.J., Verderame, M.F., Zagon, I.S. (2009). The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation. Mol Biol Cell 20:319–327.
   PubMed Web of Science ®Google Scholar
• Cheng, F., McLaughlin, P.J., Zagon, I.S. (2010). Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking. Exp Biol Med (Maywood) 235:1093–1101.
   Web of Science ®Google Scholar
• Comer, S.D., Sullivan, M.A., Hulse, G.K. (2007). Sustained-release naltrexone: novel treatment for opioid dependence. Expert Opin Investig Drugs 16:1285–1294.
   PubMed Web of Science ®Google Scholar
• Cooper, O.B., Brown, T.T., Dobs, A.S. (2003). Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis 37 (Suppl 2):S132–S136.
   Google Scholar
• Darke, S., Degenhardt, L., Mattick, R. (2007). Mortality amongst illicit drug users: epidemiology, causes, and intervention. Sydney, Australia: Cambridge University Press.
   Google Scholar
• Darke, S., Duflou, J., Torok, M. (2010). The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug Alcohol Depend 106:1–6.
   PubMed Web of Science ®Google Scholar
• Darke, S., Kaye, S., Duflou, J. (2006). Systemic disease among cases of fatal opioid toxicity. Addiction 101:1299–1305.
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend 105:9–15.
   PubMed Web of Science ®Google Scholar
• Fadini, G.P., Ceolotto, G., Pagnin, E., de Kreutzenberg, S., Avogaro, A. (2011). At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell 10:10–17.
   PubMed Web of Science ®Google Scholar
• Feero, W.G., Guttmacher, A.E., McCarthy, M.I. (2010). Genomics, type 2 diabetes, and obesity. N Engl J Med 363:2339–2350.
   PubMed Web of Science ®Google Scholar
• Fowler, J.S., Volkow, N.D., Kassed, C.A., Chang, L. (2007). Imaging the addicted human brain. Sci Pract Perspect 3:4–16.
   PubMedGoogle Scholar
• Franceschi, C., Monti, D., Sansoni, P., Cossarizza, A. (1995). The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 16:12–16.
   PubMedGoogle Scholar
• Ghavamzadeh, A., Moussavi, A., Jahani, M., Rastegarpanah, M., Iravani, M. (2001). Esophageal cancer in Iran. Semin Oncol 28:153–157.
   PubMed Web of Science ®Google Scholar
• Harvey, B.K., Hope, B.T., Shaham, Y. (2007). Tolerance to opiate reward: role of midbrain IRS2-Akt pathway. Nat Neurosci 10:9–10.
   PubMed Web of Science ®Google Scholar
• Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., et al. (2007). A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316:1491–1493.
   PubMed Web of Science ®Google Scholar
• Howard, A.A., Floris-Moore, M., Arnsten, J.H., Santoro, N., Fleischer, N., Lo, Y., et al. (2005). Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 40:1492–1499.
   PubMed Web of Science ®Google Scholar
• Howard, A.A., Floris-Moore, M., Lo, Y., Arnsten, J.H., Fleischer, N., Klein, R.S. (2006). Abnormal glucose metabolism among older men with or at risk of HIV infection. HIV Med 7:389–396.
   PubMed Web of Science ®Google Scholar
• Hser, Y.I., Gelberg, L., Hoffman, V., Grella, C.E., McCarthy, W., Anglin, M.D. (2004). Health conditions among aging narcotics addicts: medical examination results. J Behav Med 27:607–622.
   PubMed Web of Science ®Google Scholar
• Hutchinson, M.R., Lewis, S.S., Coats, B.D., Rezvani, N., Zhang, Y., Wieseler, J.L., et al. (2010). Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 167:880–893.
   PubMed Web of Science ®Google Scholar
• Hutchinson, M.R., Zhang, Y., Shridhar, M., Evans, J.H., Buchanan, M.M., Zhao, T.X., et al. (2010). Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 24:83–95.
   PubMed Web of Science ®Google Scholar
• Joint United Nations Program on HIV/AIDS (UNAIDS). (2006). At risk and neglected: four key populations (chapter 5). In: 2006 report on the global AIDS epidemic. Geneva: UNAIDS.
   Google Scholar
• Joint United Nations Program on HIV/AIDS (UNAIDS). (2008). 2008 report on the global AIDS epidemic. Geneva: UNAIDS.
   Google Scholar
• Keipert, S., Voigt, A., Klaus, S. (2011). Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice. Aging Cell 10:122–136.
   PubMed Web of Science ®Google Scholar
• Kim, T.W., Alford, D.P., Malabanan, A., Holick, M.F., Samet, J.H. (2006). Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 85:258–262.
   PubMed Web of Science ®Google Scholar
• Ko, G.T., Chan, J.C., Woo, J., Lau, E., Yeung, V.T., Chow, C.C., et al. (1998). Glycated haemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med 15:573–578.
   PubMed Web of Science ®Google Scholar
• Kolarzyk, E., Pach, D., Wojtowicz, B., Szpanowska-Wohn, A., Szurkowska, M. (2005). Nutritional status of the opiate dependent persons after 4 years of methadone maintenance treatment. Przegl Lek 62:373–377.
   PubMedGoogle Scholar
• Krishnamurthy, J., Ramsey, M.R., Ligon, K.L., Torrice, C., Koh, A., Bonner-Weir, S., et al. (2006). p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443:453–457.
   PubMed Web of Science ®Google Scholar
• Krupitsky, E.M., Blokhina, E.A. (2010). Long-acting depot formulations of naltrexone for heroin dependence: a review. Curr Opin Psychiatry 23:210–214.
   PubMed Web of Science ®Google Scholar
• Li, Y., Eitan, S., Wu, J., Evans, C.J., Kieffer, B., Sun, X., et al. (2003). Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 23:6255–6266.
   PubMed Web of Science ®Google Scholar
• McCarthy, L., Wetzel, M., Sliker, J.K., Eisenstein, T.K., Rogers, T.J. (2001). Opioids, opioid receptors, and the immune response. Drug Alcohol Depend 62:111–123.
   PubMed Web of Science ®Google Scholar
• McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D.R., et al. (2007). A common allele on chromosome 9 associated with coronary heart disease. Science 316:1488–1491.
   PubMed Web of Science ®Google Scholar
• Mousavi, M.R., Damghani, M.A., Haghdoust, A.A., Khamesipour, A. (2003). Opium and risk of laryngeal cancer. Laryngoscope 113:1939–1943.
   PubMed Web of Science ®Google Scholar
• Neri, S., Bruno, C.M., Pulvirenti, D., Malaguarnera, M., Italiano, C., Mauceri, B., et al. (2005). Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers. Psychopharmacology (Berl) 179:700–704.
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes, E., Marsh, D., Schecter, M.T. (2009). Diacetylmorphine versus methadone for the treatment of heroin addiction. N Engl J Med 361:2193–2195.
   PubMed Web of Science ®Google Scholar
• Pasmant, E., Laurendeau, I., Heron, D., Vidaud, M., Vidaud, D., Bieche, I. (2007). Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67:3963–3969.
   PubMed Web of Science ®Google Scholar
• Pasmant, E., Sabbagh, A., Vidaud, M., Bièche, I. (2010). ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 25:444–448.
   PubMed Web of Science ®Google Scholar
• Passariello, N., Giugliano, D., Ceriello, A., Chiariello, A., Sgambato, S., D’Onofrio, F. (1986). Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest 9:353–357.
   PubMed Web of Science ®Google Scholar
• Passariello, N., Giugliano, D., Quatraro, A., Consoli, G., Sgambato, S., Torella, R., et al. (1983). Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism 32:1163–1165.
   PubMed Web of Science ®Google Scholar
• Pillai, R., Nair, B.S., Watson, R.R. (1991). AIDS, drugs of abuse and the immune system: a complex immunotoxicological network. Arch Toxicol 65:609–617.
   PubMed Web of Science ®Google Scholar
• Reece, A.S. (2007a). Hair graying in substance addiction. Arch Dermatol 143:116–118.
   PubMed Web of Science ®Google Scholar
• Reece, A.S. (2007b). Dentition of addiction in Queensland: poor dental status and major contributing drugs. Aust Dent J 52:144–149.
   PubMed Web of Science ®Google Scholar
• Reece, A.S. (2007c). Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Subst Abuse Treat Prev Policy 2:35–49.
   PubMed Web of Science ®Google Scholar
• Reece, A.S. (2008a). An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey. Br Dent J 205:E22.
   PubMed Web of Science ®Google Scholar
• Reece, A.S. (2008b). Experience of road and other trauma by the opiate dependent patient: a survey report. Subst Abuse Treat Prev Policy 3:10.
   PubMed Web of Science ®Google Scholar
• Reece A.S. (2009). Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy. BMJ Case Rep 2009: bcr0820080799. [Epub 2009 Apr 14]
   Google Scholar
• Reece, A.S. (2010). Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing. Med Hypotheses 75:613–619.
   PubMed Web of Science ®Google Scholar
• Reece A.S. (2011). Hypothalamic opioid-melanocortin appetitive balance and addictive craving. Med Hypotheses 76:132–137.
   PubMed Web of Science ®Google Scholar
• Reece, A.S., Davidson, P. (2007). Deficit of circulating stem-progenitor cells in opiate addiction: a pilot study. Subst Abuse Treat Prev Policy 2:19–28.
   PubMed Web of Science ®Google Scholar
• Rosen, D., Smith, M.L., Reynolds, C.F. 3rd. (2008). The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry 16:488–497.
   PubMed Web of Science ®Google Scholar
• Russo, S.J., Bolanos, C.A., Theobald, D.E., DeCarolis, N.A., Renthal, W., Kumar, A., et al. (2007). IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10:93–99.
   PubMed Web of Science ®Google Scholar
• Sadeghian, S., Darvish, S., Davoodi, G., Salarifar, M., Mahmoodian, M., Fallah, N., et al. (2007). The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 14:715–717.
   PubMed Web of Science ®Google Scholar
• Selvin, E., Steffes, M.W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800–811.
   PubMed Web of Science ®Google Scholar
• Stefano, G.B., Kream, R.M. (2010). Dopamine, morphine, and nitric oxide: an evolutionary signaling triad. CNS Neurosci Ther 16:e124–e137. [Epub 2009 Nov 13]
   Google Scholar
• Tsui, H., Winer, S., Chan, Y., Truong, D., Tang, L., Yantha, J., et al. (2008). Islet glia, neurons, and beta cells. Ann N Y Acad Sci 1150:32–42.
   PubMed Web of Science ®Google Scholar
• Volkow, N.D., Fowler, J.S., Wang, G.J. (2003). The addicted human brain: insights from imaging studies. J Clin Invest 111:1444–1451.
   PubMed Web of Science ®Google Scholar
• Ward, J., Mattick, R.P., Hall, W. (1997). Methadone maintenance treatment and other opioid replacement therapies (vol. 1). Amsterdam: Harwood Academic.
   Google Scholar
• Wijsman, C.A., Rozing, M.P., Streefland, T.C.M., le Cessie, S., Mooijaart, S.P., Slagboom, P.E., et al. (2011). Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10:114–121.
   PubMed Web of Science ®Google Scholar
• Wikby, A., Ferguson, F., Forsey, R., Thompson, J., Strindhall, J., Lofgren, S., et al. (2005). An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 60:556–565.
   PubMed Web of Science ®Google Scholar
• Will, M.J., Pratt, W.E., Kelley, A.E. (2006). Pharmacological characterization of high-fat feeding induced by opioid stimulation of the ventral striatum. Physiol Behav 89:226–234.
   PubMed Web of Science ®Google Scholar
• Wodak, A. (1998). The Swiss heroin trials. Further studies of heroin treatment are needed. BMJ 317:1011–1012.
   PubMed Web of Science ®Google Scholar
• Zagon, I.S., Verderame, M.F., McLaughlin, P.J. (2002). The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 38:351–376.
   PubMed Web of Science ®Google Scholar
• Zhu, W., Esch, T., Kream, R.M., Stefano, G.B. (2008). Converging cellular processes for substances of abuse: endogenous morphine. Neuro Endocrinol Lett 29:63–66.
   PubMed Web of Science ®Google Scholar